A Study of Remote Electrical Neuromodulation for Acute Procedural Pain
Part of paid clinical trials in Scottsdale, Arizona.
- Sponsor
- Mayo Clinic
- Study ID
- NCT05730556
- Status
- Terminated
Conditions
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - 75 Years
- Healthy Volunteers
- Not accepted
Interventions
- Nerivio ® — DEVICENon-invasive wearable, remote electrical neuromodulation (REN) device controlled by a smartphone application worn on an armband on the upper arm.
- Sham — DEVICEElectrical stimulation to mimic study treatment intervention
Study Details
The purpose of this study is to assess the effectiveness of using remote electrical neuromodulation, using the Nerivio ® device, to relieve pain associated with receiving onabotulinumtoxinA (Botox) injections for chronic migraine prevention.
Key Dates
- Start date
- Feb 13, 2023
- Status verified
- Sep 2025
- Primary completion
- Sep 9, 2024
- Completion
- Sep 9, 2024
Study Design
- Enrollment
- 80 participants (actual)
- Allocation
- RANDOMIZED
- Intervention model
- CROSSOVER
- Primary purpose
- TREATMENT
Arms
- Experimental: Electrical Neuromodulation, Then ShamSubjects will first have the Nerivio ® applied 20 minutes prior to clinical care onabotulinumtoxinA (Botox) injection, and continue to wear the device for a total of 40 to 45 minutes at week 12. Subjects will then have the sham device applied 20 minutes prior to clinical care onabotulinumtoxinA (Botox) injection, and continue to wear the device for a total of 40 to 45 minutes at week 24.
- Experimental: Sham, Then Electrical NeuromodulationSubjects will first have the sham device applied 20 minutes prior to clinical care onabotulinumtoxinA (Botox) injection, and continue to wear the device for a total of 40 to 45 minutes at week 12. Subjects will then have the Nerivio ® applied 20 minutes prior to clinical care onabotulinumtoxinA (Botox) injection, and continue to wear the device for a total of 40 to 45 minutes at week 24.
Primary Outcome Measure
Change in Pain Intensity Measured by Visual Analog Scale (VAS) [ Time Frame: Baseline, Week 12, Week 24 ]
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Mayo Clinic in Arizona | Scottsdale | Arizona | 85259 | - |
Find similar trials in Scottsdale, AZ
By condition
By specialty
By research site
Related Studies
- Determining the Utility of a Behavioral Intervention in Chronic MigraineRecruiting · Mayo Clinic · Phoenix, Arizona
- Responding With Evidence and Access for Childhood HeadachesRecruiting · Children's Hospital Medical Center, Cincinnati · Birmingham, Alabama
- A Study to Evaluate IPN10200 Safety and Efficacy in the Prevention of Episodic or Chronic Migraine in AdultsPHASE2 · Recruiting · Ipsen · Birmingham, Alabama
- A Clinical Trial to Evaluate Efficacy and Safety of Xeomin® Injections for Preventing Chronic MigrainePHASE3 · Recruiting · Merz Therapeutics GmbH · Chandler, Arizona